| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.915 | 57.582 | 49.880 | 59.075 | 60.342 | 174.413 | 502.559 | 437.092 |
| Total Income - EUR | - | - | 1.915 | 57.582 | 49.880 | 82.168 | 180.218 | 142.859 | 542.286 | 1.276.822 |
| Total Expenses - EUR | - | - | 806 | 47.249 | 14.992 | 32.993 | 42.427 | 38.919 | 359.030 | 236.619 |
| Gross Profit/Loss - EUR | - | - | 1.109 | 10.333 | 34.888 | 49.176 | 137.791 | 103.940 | 183.256 | 1.040.203 |
| Net Profit/Loss - EUR | - | - | 1.052 | 9.757 | 34.389 | 48.580 | 137.183 | 103.389 | 183.236 | 1.040.201 |
| Employees | - | - | 1 | 3 | 3 | 3 | 6 | 6 | 1 | 1 |
Check the financial reports for the company - Biofood Innovation - Bfi Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 30.796 | 21.725 | 9.993 | 21.950 | 66.584 | 272.451 | 951.304 | 887.072 |
| Current Assets | - | - | 5.748 | 31.584 | 78.180 | 131.418 | 200.067 | 874.480 | 1.419.722 | 2.118.538 |
| Inventories | - | - | 4.443 | 4.470 | 4.383 | 12.964 | 100.460 | 70.700 | 250.118 | 493.630 |
| Receivables | - | - | 0 | 24.794 | 73.730 | 82.127 | 86.083 | 723.005 | 1.007.546 | 1.613.535 |
| Cash | - | - | 1.306 | 2.320 | 66 | 36.327 | 13.523 | 80.775 | 162.057 | 11.374 |
| Shareholders Funds | - | - | 1.161 | 9.864 | 44.484 | 78.700 | 215.514 | 323.941 | 506.195 | 1.720.806 |
| Social Capital | - | - | 109 | 107 | 527 | 517 | 505 | 507 | 505 | 503 |
| Debts | - | - | 35.383 | 8.885 | 9.799 | 41.420 | 18.626 | 318.134 | 419.463 | 426.764 |
| Income in Advance | - | - | 0 | 34.559 | 33.890 | 33.248 | 32.510 | 504.856 | 1.516.124 | 904.707 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6201 - 6201" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Biofood Innovation - Bfi Srl